ENTITY
Hua Medicine Ltd

Hua Medicine Ltd (2552 HK)

31
Analysis
Health CareChina
Hua Medicine operates as a drug development company. The Company develops and sells glucokinase activator and other products. Hua Medicine markets its products throughout China.
more
15 Oct 2018 19:25

Innovent Biologics IPO Valuation: Surprisingly Grounded in Reality

Innovent Biologics Inc (1641475D HK) launched its Hong Kong IPO today. The mid-point of Innovent's IPO price range of HK$12.50-14.00 per share...

Logo
708 Views
Share
02 Oct 2018 06:24

Innovent Biologics IPO Preview: Limited Upside on China's PD-1 Drug Market Compared to BeiGene

Innovent Biologics Inc (1641475D HK) is the fourth pre-profit biotech firm to IPO in Hong Kong since Ascletis Pharma Inc (1672 HK), BeiGene Ltd...

Logo
704 Views
Share
02 Oct 2018 06:08

Last Week in GER Research: Haidilao, Popflops, Bitmain, Shandong Gold, Niu and China Renaissance

Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight 25% potential downside at Haidilao as...

Logo
397 Views
Share
bearishMeituan
24 Sep 2018 06:21

Last Week in GER Research: Meituan, IPO Trading Strategy, Shandong Gold, Maoyan and Viomi

Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight that Meituan is closer to fair value...

Logo
336 Views
Share
17 Sep 2018 16:50

Hua Medicine (华领医药) Post-Listing: Thin Volume and Limited Upside

Hua Medicine is the third biotech companies to list in Hong Kong without a profit under the amended listing rules. The stock debuted last Friday...

Logo
450 Views
Share
x